Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is unbelievable 52 week low was .26 and were at .267

I am unaware of how the reclassification of the previous shareholder distributions from dividends to return of capital would in any way affect the profit or loss of the company.

Please educate me.

Share
New Message
Please login to post a reply